Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_1
2
50%
Ph phase_2
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Terminated(1)

Detailed Status

Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (50.0%)
Phase 21 (25.0%)
N/A1 (25.0%)

Trials by Status

not_yet_recruiting125%
recruiting250%
terminated125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Using Cannabis to Treat Restless Legs Syndrome

NCT06863740
not_yet_recruitingphase_1

A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users

NCT05320367
recruitingphase_2

Cannabis' Impact on Alcohol Consumption

NCT05389930
terminatedphase_1

Cannabis Effects on Electroencephalography

NCT04316598

Clinical Trials (4)

Showing 4 of 4 trials
NCT06863740Not Applicable

Using Cannabis to Treat Restless Legs Syndrome

Recruiting
NCT05320367Phase 1

A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users

Not Yet Recruiting
NCT05389930Phase 2

Cannabis' Impact on Alcohol Consumption

Recruiting
NCT04316598Phase 1

Cannabis Effects on Electroencephalography

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4